These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19540113)
1. First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa. Verghese J; Liang A; Sidhu PP; Hindle M; Zhou Q; Desai UR Bioorg Med Chem Lett; 2009 Aug; 19(15):4126-9. PubMed ID: 19540113 [TBL] [Abstract][Full Text] [Related]
2. A simple, general approach of allosteric coagulation enzyme inhibition through monosulfated hydrophobic scaffolds. Sidhu PS; Zhou Q; Desai UR Bioorg Med Chem Lett; 2014 Dec; 24(24):5716-5720. PubMed ID: 25453807 [TBL] [Abstract][Full Text] [Related]
3. Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparin. Henry BL; Desai UR Thromb Res; 2014 Nov; 134(5):1123-9. PubMed ID: 25242245 [TBL] [Abstract][Full Text] [Related]
4. Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition. Abdel Aziz MH; Sidhu PS; Liang A; Kim JY; Mosier PD; Zhou Q; Farrell DH; Desai UR J Med Chem; 2012 Aug; 55(15):6888-97. PubMed ID: 22788964 [TBL] [Abstract][Full Text] [Related]
5. Rational design of potent, small, synthetic allosteric inhibitors of thrombin. Sidhu PS; Liang A; Mehta AY; Abdel Aziz MH; Zhou Q; Desai UR J Med Chem; 2011 Aug; 54(15):5522-31. PubMed ID: 21714536 [TBL] [Abstract][Full Text] [Related]
6. Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition. Sidhu PS; Abdel Aziz MH; Sarkar A; Mehta AY; Zhou Q; Desai UR J Med Chem; 2013 Jun; 56(12):5059-70. PubMed ID: 23718540 [TBL] [Abstract][Full Text] [Related]
7. Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors. Argade MD; Mehta AY; Sarkar A; Desai UR J Med Chem; 2014 Apr; 57(8):3559-69. PubMed ID: 24666186 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors. Buckman BO; Mohan R; Koovakkat S; Liang A; Trinh L; Morrissey MM Bioorg Med Chem Lett; 1998 Aug; 8(16):2235-40. PubMed ID: 9873520 [TBL] [Abstract][Full Text] [Related]
9. A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin. Afosah DK; Verespy S; Al-Horani RA; Boothello RS; Karuturi R; Desai UR Bioorg Med Chem Lett; 2018 Apr; 28(6):1101-1105. PubMed ID: 29459207 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors. Nar H; Bauer M; Schmid A; Stassen JM; Wienen W; Priepke HW; Kauffmann IK; Ries UJ; Hauel NH Structure; 2001 Jan; 9(1):29-37. PubMed ID: 11342132 [TBL] [Abstract][Full Text] [Related]
11. A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. Henry BL; Monien BH; Bock PE; Desai UR J Biol Chem; 2007 Nov; 282(44):31891-9. PubMed ID: 17804413 [TBL] [Abstract][Full Text] [Related]
12. Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths. Wagenvoord R; Al Dieri R; van Dedem G; Béguin S; Hemker HC Thromb Res; 2008; 122(2):237-45. PubMed ID: 18045667 [TBL] [Abstract][Full Text] [Related]
13. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies. Rezaie AR; Olson ST Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624 [TBL] [Abstract][Full Text] [Related]
14. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3. Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889 [TBL] [Abstract][Full Text] [Related]
15. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats. Hérault JP; Bernat A; Gaich C; Herbert M Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of acylguanidine FXa inhibitors. O'Connor SP; Atwal K; Li C; Liu EC; Seiler SM; Shi M; Shi Y; Stein PD; Wang Y Bioorg Med Chem Lett; 2008 Aug; 18(16):4696-9. PubMed ID: 18644722 [TBL] [Abstract][Full Text] [Related]
17. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides. Al-Horani RA; Desai UR J Med Chem; 2014 Jun; 57(11):4805-18. PubMed ID: 24844380 [TBL] [Abstract][Full Text] [Related]